Volume: March 2024, Issue 1

Mar 28, 2024 | Hot Topics

AARS News

  • Register now for the 11th Annual AARS Scientific Symposium
  • AARS Call for Grant Applications
  • Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products

New Medical Research

  • Development of solid lipid microparticles (SLMs) containing asiatic acid for topical treatment of acne: Characterization, stability, in vitro and in vivo anti-acne assessment.
  • Early and sustained acne lesion reductions with fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel.
  • A novel systems-wide approach in addressing acne with a multi-targeting nutraceutical.
  • Treatment of erythematous acne scars using 595-nm pulsed dye laser combined with 1565-nm ResurFX nonablative fractional laser.
  • Investigating the impact of added profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single-blinded, split-face randomized trial.
  • Rhizoma paridis saponins attenuate gram-negative bacteria-induced inflammatory acne by binding to KEAP1 and modulating Nrf2 and MAPK pathways.
  • NLRP3 inflammasome activation and NETosis positively regulate each other and exacerbate proinflammatory responses: implications of NETosis inhibition for acne skin inflammation treatment.
  • Interrupting an IFN-γ-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne.
  • Novel antimicrobial peptides against Cutibacterium acnes designed by deep learning
  • Anatomical variants of acne differ in their impact on social perception.
  • Anti-bacterial activity of green synthesized silver and zinc oxide nanoparticles against Propionibacterium acnes.
  • Alcohol promotes lipogenesis in sebocytes-implications for acne.
  • Lack of association of acne severity with depression, anxiety, stress, and eating attitudes: A cross-sectional study.
  • Topical 10% tranexamic acid with and without microneedling in the treatment of erythematotelangiectatic rosacea: A split-face comparative study.

Clinical Reviews

  • Hidradenitis suppurativa-related autoinflammatory syndromes: An updated review on the Clinics, genetics, and treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and rarer forms.
  • Rosacea: Pathogenesis and therapeutic correlates.
  • Management of acne in pregnancy.
  • Atrophic postacne scar treatment: Narrative review.
  • PCOS stratification for precision diagnostics and treatment.
  • Recent advances in the management of rosacea through natural compounds.
  • Acne and pregnancy: A clinical review and practice pearls.

Related Posts

Volume: April 2024, Issue 1

Volume: April 2024, Issue 1

AARS News   Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products New Medical...

read more
Volume: February 2024, Issue 1

Volume: February 2024, Issue 1

AARS News Register now for the 17th Annual AARS Networking Reception Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications AARS Reacts to Acne Treatment Guidelines New Medical Research Prevalence of acne and its impact on quality...

read more
Volume: January 2024, Issue 1

Volume: January 2024, Issue 1

AARS News Register Now to Connect with the AARS in San Diego on March 8, 2024! Save the Date: 11th Annual AARS Scientific Symposium New Medical Research Acne vulgaris: Clinical aspects and treatments. Efficacy and safety of solid-state dual-wavelength lasers for the...

read more
Volume: November 2023, Issue 1

Volume: November 2023, Issue 1

AARS Blog News Cabtreo™ (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) topical gel approved for the treatment of acne vulgaris. UK regulatory agency places new restrictions on isotretinoin prescribing. FDA approves Cosentyx for treatment of hidradenitis...

read more

AARS TOPICS

RELATED POSTS

RECENT POSTS